Marshall Wace’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $25.9M | Sell |
204,677
-2,105,838
| -91% | -$277M | 0.02% | 615 |
|
|
2026
Q1 | $322M | Buy |
2,310,515
+1,517,130
| +191% | +$212M | 0.32% | 37 |
|
|
2025
Q4 | $97.4M | Sell |
793,385
-1,108,095
| -58% | -$135M | 0.09% | 170 |
|
|
2025
Q3 | $211M | Sell |
1,901,480
-49,333
| -3% | -$5.61M | 0.21% | 67 |
|
|
2025
Q2 | $216M | Buy |
1,950,813
+1,176,946
| +152% | +$125M | 0.24% | 64 |
|
|
2025
Q1 | $86.7M | Sell |
773,867
-442,931
| -36% | -$45.7M | 0.11% | 165 |
|
|
2024
Q4 | $112M | Buy |
1,216,798
+193,133
| +19% | +$17.4M | 0.14% | 131 |
|
|
2024
Q3 | $85.8M | Buy |
1,023,665
+903,149
| +749% | +$68.9M | 0.1% | 170 |
|
|
2024
Q2 | $8.27M | Buy |
+120,516
| New | +$8.04M | 0.01% | 818 |
|
|
2023
Q3 | – | Sell |
-39,190
| Closed | -$3.02M | – | 2377 |
|
|
2023
Q2 | $3.02M | Sell |
39,190
-5,035,412
| -99% | -$402M | 0.01% | 1221 |
|
|
2023
Q1 | $421M | Buy |
5,074,602
+644,672
| +15% | +$53.4M | 0.89% | 9 |
|
|
2022
Q4 | $380M | Buy |
4,429,930
+1,064,987
| +32% | +$84.3M | 0.86% | 6 |
|
|
2022
Q3 | $208M | Buy |
3,364,943
+381,493
| +13% | +$24.1M | 0.45% | 24 |
|
|
2022
Q2 | $184M | Buy |
2,983,450
+493,011
| +20% | +$30.5M | 0.38% | 41 |
|
|
2022
Q1 | $148M | Buy |
2,490,439
+2,462,555
| +8,831% | +$157M | 0.28% | 63 |
|
|
2021
Q4 | $2.02M | Buy |
27,884
+18,284
| +190% | +$1.26M | ﹤0.01% | 2032 |
|
|
2021
Q3 | $671K | Sell |
9,600
-114,496
| -92% | -$8.04M | ﹤0.01% | 2245 |
|
|
2021
Q2 | $8.55M | Buy |
124,096
+75,637
| +156% | +$5.05M | 0.04% | 559 |
|
|
2021
Q1 | $3.13M | Sell |
48,459
-40,867
| -46% | -$2.64M | 0.01% | 1088 |
|
|
2020
Q4 | $5.2M | Buy |
+89,326
| New | +$5.39M | 0.03% | 566 |
|
|
2020
Q2 | – | Sell |
-3,799
| Closed | -$284K | – | 1700 |
|
|
2020
Q1 | $284K | Sell |
3,799
-452,954
| -99% | -$31.3M | ﹤0.01% | 1111 |
|
|
2019
Q4 | $29.7M | Sell |
456,753
-510,190
| -53% | -$33.2M | 0.2% | 120 |
|
|
2019
Q3 | $61.3M | Buy |
966,943
+307,406
| +47% | +$20.1M | 0.48% | 33 |
|
|
2019
Q2 | $44.6M | Buy |
+659,537
| New | +$43.4M | 0.37% | 46 |
|
|
2019
Q1 | – | Sell |
-123,013
| Closed | -$7.7M | – | 1840 |
|
|
2018
Q4 | $7.7M | Sell |
123,013
-134,351
| -52% | -$9.39M | 0.08% | 316 |
|
|
2018
Q3 | $19.9M | Buy |
257,364
+241,875
| +1,562% | +$18.3M | 0.17% | 168 |
|
|
2018
Q2 | $1.1M | Sell |
15,489
-185,098
| -92% | -$13.1M | 0.02% | 501 |
|
|
2018
Q1 | $15.1M | Buy |
+200,587
| New | +$15.9M | 0.63% | 43 |
|
|
2017
Q4 | – | Sell |
-17,562
| Closed | -$1.42M | – | 431 |
|
|
2017
Q3 | $1.42M | Sell |
17,562
-144,239
| -89% | -$11M | 0.07% | 193 |
|
|
2017
Q2 | $11.5M | Buy |
+161,801
| New | +$10.8M | 0.51% | 49 |
|
|
2017
Q1 | – | Sell |
-198,367
| Closed | -$14.2M | – | 462 |
|
|
2016
Q4 | $14.2M | Sell |
198,367
-355,427
| -64% | -$26.4M | 0.09% | 254 |
|
|
2016
Q3 | $43.8M | Sell |
553,794
-203,420
| -27% | -$16.5M | 0.31% | 81 |
|
|
2016
Q2 | $63.2M | Buy |
757,214
+167,189
| +28% | +$14.8M | 0.53% | 40 |
|
|
2016
Q1 | $54.2M | Sell |
590,025
-274,067
| -32% | -$24.7M | 0.52% | 52 |
|
|
2015
Q4 | $87.4M | Sell |
864,092
-172,835
| -17% | -$18M | 0.82% | 14 |
|
|
2015
Q3 | $102M | Buy |
1,036,927
+883,381
| +575% | +$98.1M | 1.25% | 8 |
|
|
2015
Q2 | $18M | Buy |
153,546
+99,995
| +187% | +$10.9M | 0.23% | 112 |
|
|
2015
Q1 | $5.25M | Sell |
53,551
-233,247
| -81% | -$23.7M | 0.07% | 306 |
|
|
2014
Q4 | $27M | Sell |
286,798
-153,969
| -35% | -$15.9M | 0.36% | 74 |
|
|
2014
Q3 | $46.9M | Buy |
440,767
+327,344
| +289% | +$32.1M | 0.68% | 29 |
|
|
2014
Q2 | $9.4M | Buy |
113,423
+20,999
| +23% | +$1.63M | 0.14% | 188 |
|
|
2014
Q1 | $6.55M | Buy |
+92,424
| New | +$7.25M | 0.12% | 206 |
|
Other funds holding GILD
Marshall Wace's GILD Position: Q2 2026 in Review
Marshall Wace reduced its Gilead Sciences (GILD) stake by 91% in Q2 2026, selling an estimated $277M and leaving 204,677 shares worth $25.9M. The position accounts for 0.02% of the portfolio, ranked #615.
Marshall Wace first reported a position in GILD in Q1 2014 and has held it in 42 quarters since. The position peaked at $421M in Q1 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Marshall Wace held 204,677 shares of Gilead Sciences worth $25.9M as of Q2 2026.
- Marshall Wace sold 2,105,838 Gilead Sciences shares in Q2 2026, an estimated $277M.
- Gilead Sciences made up 0.02% of Marshall Wace's portfolio in Q2 2026, its #615 holding.
- Marshall Wace first reported a position in Gilead Sciences in Q1 2014 and has held it in 42 quarters since.
- Marshall Wace's Gilead Sciences position peaked at $421M in Q1 2023.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.